Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010-2016.

Shirin ArdeshirrouhanifardHuijun AnRavi K GoyalMukaila A RajiJodi B SegalG Caleb AlexanderHemalkumar B Mehta

Published in: Pharmacotherapy (2022)

Nearly 7 out of 10 patients with cancer and NVAF did not receive anticoagulation. Use of DOACs increased from 2010 to 2016, with a corresponding decline in warfarin use. DOACs are used less than warfarin among those at higher risk of stroke.

Keyphrases

atrial fibrillation
oral anticoagulants
direct oral anticoagulants
left atrial
catheter ablation
left atrial appendage
papillary thyroid
heart failure
squamous cell
percutaneous coronary intervention
venous thromboembolism
squamous cell carcinoma
childhood cancer
young adults
left ventricular
mitral valve